Hormoz Ayromlou

1.1k total citations
48 papers, 813 citations indexed

About

Hormoz Ayromlou is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Hormoz Ayromlou has authored 48 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 11 papers in Neurology and 9 papers in Immunology. Recurrent topics in Hormoz Ayromlou's work include Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (6 papers) and MicroRNA in disease regulation (4 papers). Hormoz Ayromlou is often cited by papers focused on Multiple Sclerosis Research Studies (20 papers), Peripheral Neuropathies and Disorders (6 papers) and MicroRNA in disease regulation (4 papers). Hormoz Ayromlou collaborates with scholars based in Iran, United States and Netherlands. Hormoz Ayromlou's co-authors include Mehdi Yousefi, Sanam Dolati, Reza Rikhtegar, Zohreh Babaloo, Majid Ahmadi, Mohammad Nouri, Ali Esfahani, Zohreh Ghoreishi, Mohammad Asghari Jafarabadi and Faroogh Marofi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Gene.

In The Last Decade

Hormoz Ayromlou

45 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hormoz Ayromlou Iran 15 251 147 135 123 107 48 813
Hao Bai China 23 589 2.3× 277 1.9× 117 0.9× 212 1.7× 139 1.3× 66 1.6k
Hana Farhangkhoee Canada 14 313 1.2× 132 0.9× 51 0.4× 56 0.5× 53 0.5× 19 897
Naqi Lian China 22 386 1.5× 130 0.9× 99 0.7× 59 0.5× 92 0.9× 39 1.1k
Rong Xie China 18 468 1.9× 52 0.4× 139 1.0× 124 1.0× 71 0.7× 67 965
Zhiming Yang China 18 439 1.7× 64 0.4× 62 0.5× 121 1.0× 125 1.2× 60 972
Congrui Liao China 11 437 1.7× 93 0.6× 206 1.5× 42 0.3× 100 0.9× 16 886
Xinhua Zhou China 18 307 1.2× 82 0.6× 60 0.4× 100 0.8× 74 0.7× 65 740
Yue Yang China 22 478 1.9× 125 0.9× 47 0.3× 63 0.5× 103 1.0× 48 1.2k
Mingyan Guo China 16 260 1.0× 121 0.8× 61 0.5× 108 0.9× 131 1.2× 32 706
Jyotirmaya Behera United States 21 748 3.0× 215 1.5× 62 0.5× 77 0.6× 65 0.6× 42 1.2k

Countries citing papers authored by Hormoz Ayromlou

Since Specialization
Citations

This map shows the geographic impact of Hormoz Ayromlou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hormoz Ayromlou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hormoz Ayromlou more than expected).

Fields of papers citing papers by Hormoz Ayromlou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hormoz Ayromlou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hormoz Ayromlou. The network helps show where Hormoz Ayromlou may publish in the future.

Co-authorship network of co-authors of Hormoz Ayromlou

This figure shows the co-authorship network connecting the top 25 collaborators of Hormoz Ayromlou. A scholar is included among the top collaborators of Hormoz Ayromlou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hormoz Ayromlou. Hormoz Ayromlou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sorkhabi, Rana, et al.. (2024). Frequency of dry eye syndrome in patients with multiple sclerosis: A cross-sectional case-control study. SHILAP Revista de lepidopterología. 12. 7–7. 1 indexed citations
3.
Montazersaheb, Soheila, Vahid Hosseini, Houman Kahroba, et al.. (2024). Epstein-Barr virus-encoded BART9 and BART15 miRNAs are elevated in exosomes of cerebrospinal fluid from relapsing-remitting multiple sclerosis patients. Cytokine. 179. 156624–156624. 10 indexed citations
4.
Ayromlou, Hormoz, et al.. (2023). Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross‐sectional study. Journal of Neuroendocrinology. 35(6). e13288–e13288. 8 indexed citations
5.
Moghadasi, Abdorreza Naser, Fereshteh Ashtari, Seyed Mohammad Baghbanian, et al.. (2023). Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. 26(11). 647–653.
6.
Ayromlou, Hormoz, et al.. (2020). Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 44. 102264–102264. 6 indexed citations
7.
Hosseini, Arezoo, Zohreh Babaloo, Tohid Gharibi, et al.. (2020). Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease. BMC Research Notes. 13(1). 568–568. 12 indexed citations
8.
Ayromlou, Hormoz, et al.. (2020). miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta. Journal of Neuroimmunology. 342. 577212–577212. 7 indexed citations
9.
Khalili, Mohammad, et al.. (2018). Anti-Fatigue and Hypnotic Effects of a Traditional Herbal Extract on Multiple Sclerosis Patients : A Double Blind Randomized Clinical Trial. World Family Medicine Journal/Middle East Journal of Family Medicine. 16(8). 22–31. 2 indexed citations
10.
Sahraian, Mohammad Ali, Abdorreza Naser Moghadasi, Amir Reza Azimi, et al.. (2017). Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. 18. 144–151. 27 indexed citations
11.
Khaniani, Mahmoud Shekari, Ehsan Esmaili Shandiz, Hormoz Ayromlou, et al.. (2016). Genetic Analysis of the ZNF512B , SLC41A1, and ALDH2 Polymorphisms in Parkinson's Disease in the Iranian Population. Genetic Testing and Molecular Biomarkers. 20(10). 629–632. 13 indexed citations
12.
Dolati, Sanam, Zohreh Babaloo, Farhad Jadidi‐Niaragh, et al.. (2016). Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomedicine & Pharmacotherapy. 86. 343–353. 59 indexed citations
13.
Ayromlou, Hormoz, et al.. (2014). Evaluation of Chronic and Acute Effects of Gabapentin on Passive Avoidance Learning Process in Mice. SHILAP Revista de lepidopterología. 4 indexed citations
14.
Jahromi, Soodeh Razeghi, Mohammad Ali Sahraian, Fereshteh Ashtari, et al.. (2014). Islamic fasting and multiple sclerosis. BMC Neurology. 14(1). 56–56. 14 indexed citations
15.
Farhoudi, Mehdi, et al.. (2013). Time Frequency of Guillain-Barre Syndrome in Northwest of Iran. 10. 3 indexed citations
16.
Ghoreishi, Zohreh, Ali Esfahani, Abolghasem Djazayeri, et al.. (2012). Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial. BMC Cancer. 12(1). 355–355. 115 indexed citations
17.
Khoshbaten, Manouchehr, Mehdi Farhoudi, Masoud Nikanfar, et al.. (2012). Celiac disease and multiple sclerosis in the northwest of Iran. Bratislavské lekárske listy/Bratislava medical journal. 113(8). 495–497. 5 indexed citations
18.
Farhoudi, Mehdi, et al.. (2012). Dose Low dose contraceptive pills increase stroke rate? A Cross sectional study in North – West Iran. 2 indexed citations
19.
Ayromlou, Hormoz, et al.. (2011). Oxidative effect of methotrexate administration in spinal cord of rabbits.. PubMed. 61(11). 1096–9. 10 indexed citations
20.
Ayromlou, Hormoz, et al.. (2002). Sympathetic skin response in hemodialysis and renal transplantation. Transplantation Proceedings. 34(6). 2128–2128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026